Paying users zone. Data is hidden behind: .
Get 1-month access to Pfizer Inc. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
This is a one-time payment. There is no automatic renewal.
Cash Flow Statement
The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.
The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.
|Cash flow statement item||Description||The company|
|Net cash provided by operating activities||Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.||Pfizer Inc.’s net cash provided by operating activities decreased from 2018 to 2019 and from 2019 to 2020.|
|Net cash (used in) provided by investing activities||Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.||Pfizer Inc.’s net cash (used in) provided by investing activities decreased from 2018 to 2019 and from 2019 to 2020.|
|Net cash used in financing activities||Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.||Pfizer Inc.’s net cash used in financing activities increased from 2018 to 2019 but then decreased significantly from 2019 to 2020.|